{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:26:52Z","timestamp":1779362812944,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371430"],"award-info":[{"award-number":["82371430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2022ZDZX0023"],"award-info":[{"award-number":["2022ZDZX0023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12035-024-04600-y","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T22:02:17Z","timestamp":1730757737000},"page":"4854-4865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mutation Screening of ATXN1, ATXN2, and ATXN3 in Amyotrophic Lateral Sclerosis"],"prefix":"10.1007","volume":"62","author":[{"given":"Tianmi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejiang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangfan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qirui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-1151","authenticated-orcid":false,"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"4600_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01272-7","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G (2022) Amyotrophic lateral sclerosis. Lancet. https:\/\/doi.org\/10.1016\/s0140-6736(22)01272-7","journal-title":"Lancet"},{"issue":"9","key":"4600_CR2","doi-asserted-by":"publisher","first-page":"e45489","DOI":"10.7759\/cureus.45489","volume":"15","author":"P Hoxhaj","year":"2023","unstructured":"Hoxhaj P, Hastings N, Kachhadia MP, Gupta R, Sindhu U, Durve SA, Azam A, Auz Vinueza MJ et al (2023) Exploring advancements in the treatment of amyotrophic lateral sclerosis: a comprehensive review of current modalities and future prospects. Cureus 15(9):e45489. https:\/\/doi.org\/10.7759\/cureus.45489","journal-title":"Cureus"},{"issue":"5796","key":"4600_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"issue":"1","key":"4600_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41398-022-02052-3","volume":"12","author":"C Li","year":"2022","unstructured":"Li C, Liu J, Lin J, Shang H (2022) COVID-19 and risk of neurodegenerative disorders: a Mendelian randomization study. Transl Psychiatry 12(1):283. https:\/\/doi.org\/10.1038\/s41398-022-02052-3","journal-title":"Transl Psychiatry"},{"issue":"11","key":"4600_CR5","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1111\/ene.15527","volume":"29","author":"T Yang","year":"2022","unstructured":"Yang T, Wei Q, Li C, Cao B, Ou R, Hou Y, Zhang L, Gu X et al (2022) Spatial-temporal pattern of propagation in amyotrophic lateral sclerosis and effect on survival: A cohort study. Eur J Neurol 29(11):3177\u20133186. https:\/\/doi.org\/10.1111\/ene.15527","journal-title":"Eur J Neurol"},{"issue":"7310","key":"4600_CR6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466(7310):1069\u20131075. https:\/\/doi.org\/10.1038\/nature09320","journal-title":"Nature"},{"issue":"12","key":"4600_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaneurol.2014.2082","volume":"71","author":"AG Neuenschwander","year":"2014","unstructured":"Neuenschwander AG, Thai KK, Figueroa KP, Pulst SM (2014) Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis. JAMA Neurol 71(12):1529\u20131534. https:\/\/doi.org\/10.1001\/jamaneurol.2014.2082","journal-title":"JAMA Neurol"},{"key":"4600_CR8","doi-asserted-by":"publisher","first-page":"064","DOI":"10.1093\/braincomms\/fcaa064","volume":"2","author":"GHP Tazelaar","year":"2020","unstructured":"Tazelaar GHP, Boeynaems S, De Decker M, van Vugt J, Kool L, Goedee HS, McLaughlin RL, Sproviero W et al (2020) ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization. Brain Commun 2:064. https:\/\/doi.org\/10.1093\/braincomms\/fcaa064","journal-title":"Brain Commun"},{"issue":"8","key":"4600_CR9","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/brain\/awac167","volume":"145","author":"JD Glass","year":"2022","unstructured":"Glass JD, Dewan R, Ding J, Gibbs JR, Dalgard C, Keagle PJ, Shankaracharya G-R, Traynor BJ et al (2022) ATXN2 intermediate expansions in amyotrophic lateral sclerosis. Brain 145(8):2671\u20132676. https:\/\/doi.org\/10.1093\/brain\/awac167","journal-title":"Brain"},{"issue":"11","key":"4600_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/jnnp-2022-329376","volume":"93","author":"A Chio","year":"2022","unstructured":"Chio A, Moglia C, Canosa A, Manera U, Grassano M, Vasta R, Palumbo F, Gallone S et al (2022) Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats. J Neurol Neurosurg Psychiatry 93(11):1216\u20131220. https:\/\/doi.org\/10.1136\/jnnp-2022-329376","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4600_CR11","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1212\/wnl.0000000000207367","volume":"101","author":"A Chi\u00f2","year":"2023","unstructured":"Chi\u00f2 A, Moglia C, Canosa A, Manera U, Grassano M, Vasta R, Palumbo F, Gallone S et al (2023) Association of copresence of pathogenic variants related to amyotrophic lateral sclerosis and prognosis. Neurology 101(1):e83\u2013e93. https:\/\/doi.org\/10.1212\/wnl.0000000000207367","journal-title":"Neurology"},{"issue":"10","key":"4600_CR12","doi-asserted-by":"publisher","first-page":"e1921","DOI":"10.1016\/j.neurobiolaging.2011.05.015","volume":"32","author":"Y Chen","year":"1925","unstructured":"Chen Y, Huang R, Yang Y, Chen K, Song W, Pan P, Li J (1925) Shang HF (2011) Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging 32(10):e1921-1925. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.05.015","journal-title":"Neurobiol Aging"},{"issue":"7650","key":"4600_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P, Messing J, Kim HJ et al (2017) Therapeutic reduction of ataxin 2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544(7650):367\u2013371. https:\/\/doi.org\/10.1038\/nature22038","journal-title":"Nature"},{"issue":"1","key":"4600_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nbd.2011.08.021","volume":"45","author":"S Gispert","year":"2012","unstructured":"Gispert S, Kurz A, Waibel S, Bauer P, Liepelt I, Geisen C, Gitler AD, Becker T et al (2012) The modulation of amyotrophic lateral sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 45(1):356\u2013361. https:\/\/doi.org\/10.1016\/j.nbd.2011.08.021","journal-title":"Neurobiol Dis"},{"key":"4600_CR15","doi-asserted-by":"publisher","first-page":"211.e211","DOI":"10.1016\/j.neurobiolaging.2021.01.023","volume":"102","author":"C Li","year":"2021","unstructured":"Li C, Ou R, Wei Q, Shang H (2021) Shared genetic links between amyotrophic lateral sclerosis and obesity-related traits: a genome-wide association study. Neurobiol Aging 102:211.e211-211.e219. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.023","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4600_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12916-021-01903-y","volume":"19","author":"CY Li","year":"2021","unstructured":"Li CY, Yang TM, Ou RW, Wei QQ, Shang HF (2021) Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases. BMC Med 19(1):27. https:\/\/doi.org\/10.1186\/s12916-021-01903-y","journal-title":"BMC Med"},{"issue":"1","key":"4600_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","volume":"26","author":"J Humphrey","year":"2023","unstructured":"Humphrey J, Venkatesh S, Hasan R, Herb JT, de Paiva LK, K\u00fc\u00e7\u00fckali F, Byrska-Bishop M, Evani US et al (2023) Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci 26(1):150\u2013162. https:\/\/doi.org\/10.1038\/s41593-022-01205-3","journal-title":"Nat Neurosci"},{"issue":"1","key":"4600_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41467-023-36311-8","volume":"14","author":"Y Cui","year":"2023","unstructured":"Cui Y, Arnold FJ, Peng F, Wang D, Li JS, Michels S, Wagner EJ, La Spada AR, Li W (2023) Alternative polyadenylation transcriptome-wide association study identifies APA-linked susceptibility genes in brain disorders. Nat Commun 14(1):583. https:\/\/doi.org\/10.1038\/s41467-023-36311-8","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"4600_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/21678421.2014.966311","volume":"16","author":"Q Wei","year":"2015","unstructured":"Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, Bak TH, Shang H (2015) Screening for cognitive impairment in a Chinese ALS population. Amyotroph Lateral Scler Frontotemporal Degener 16(1\u20132):40\u201345. https:\/\/doi.org\/10.3109\/21678421.2014.966311","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4600_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neurobiolaging.2022.11.001","volume":"123","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Lin J, Wei Q, Li C, Hou Y, Zhang L, Ou R, Liu K et al (2023) Genetic and clinical characteristics of ALS patients with NEK1 gene variants. Neurobiol Aging 123:191\u2013199. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.11.001","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4600_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40246-023-00479-3","volume":"17","author":"C Li","year":"2023","unstructured":"Li C, Hou Y, Wei Q, Lin J, Jiang Z, Jiang Q, Yang T, Xiao Y et al (2023) Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis. Hum Genomics 17(1):28. https:\/\/doi.org\/10.1186\/s40246-023-00479-3","journal-title":"Hum Genomics"},{"issue":"7809","key":"4600_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, Collins RL, Laricchia KM et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7","journal-title":"Nature"},{"issue":"9","key":"4600_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41422-020-0322-9","volume":"30","author":"Y Cao","year":"2020","unstructured":"Cao Y, Li L, Xu M, Feng Z, Sun X, Lu J, Xu Y, Du P et al (2020) The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals. Cell Res 30(9):717\u2013731. https:\/\/doi.org\/10.1038\/s41422-020-0322-9","journal-title":"Cell Res"},{"issue":"1","key":"4600_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, Flicek P, Cunningham F (2016) The Ensembl variant effect predictor. Genome Biol 17(1):122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4","journal-title":"Genome Biol"},{"issue":"3","key":"4600_CR25","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310\u2013315. https:\/\/doi.org\/10.1038\/ng.2892","journal-title":"Nat Genet"},{"issue":"6","key":"4600_CR26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3233\/jnd-230148","volume":"10","author":"EP McCann","year":"2023","unstructured":"McCann EP, Grima N, Fifita JA, Chan Moi Fat S, Lehnert K, Henden L, Blair IP, Williams KL (2023) Characterising the genetic landscape of amyotrophic lateral sclerosis: a catalogue and assessment of over 1,000 published genetic variants. J Neuromuscul Dis 10(6):1127\u20131141. https:\/\/doi.org\/10.3233\/jnd-230148","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"4600_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q et al (2016) REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet 99(4):877\u2013885. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016","journal-title":"Am J Hum Genet"},{"issue":"11","key":"4600_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118","journal-title":"Genome Res"},{"issue":"1","key":"4600_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ de Boer","year":"2020","unstructured":"de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T, Silsby M, Menon P et al (2020) TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry 92(1):86\u201395. https:\/\/doi.org\/10.1136\/jnnp-2020-322983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4600_CR30","doi-asserted-by":"publisher","first-page":"105907","DOI":"10.1016\/j.nbd.2022.105907","volume":"175","author":"Q Jiang","year":"2022","unstructured":"Jiang Q, Lin J, Wei Q, Li C, Hou Y, Cao B, Zhang L, Ou R et al (2022) Genetic analysis of and clinical characteristics associated with ANXA11 variants in a Chinese cohort with amyotrophic lateral sclerosis. Neurobiol Dis 175:105907. https:\/\/doi.org\/10.1016\/j.nbd.2022.105907","journal-title":"Neurobiol Dis"},{"key":"4600_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2021-107965","author":"YP Chen","year":"2021","unstructured":"Chen YP, Yu SH, Wei QQ, Cao B, Gu XJ, Chen XP, Song W, Zhao B et al (2021) Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population. J Med Genet. https:\/\/doi.org\/10.1136\/jmedgenet-2021-107965","journal-title":"J Med Genet"},{"issue":"10","key":"4600_CR32","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1111\/ene.15973","volume":"30","author":"B Zhao","year":"2023","unstructured":"Zhao B, Jiang Q, Lin J, Wei Q, Li C, Hou Y, Cao B, Zhang L et al (2023) TBK1 variants in Chinese patients with amyotrophic lateral sclerosis: genetic analysis and clinical features. Eur J Neurol 30(10):3079\u20133089. https:\/\/doi.org\/10.1111\/ene.15973","journal-title":"Eur J Neurol"},{"issue":"24","key":"4600_CR33","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1212\/WNL.0b013e318278b618","volume":"79","author":"FL Conforti","year":"2012","unstructured":"Conforti FL, Spataro R, Sproviero W, Mazzei R, Cavalcanti F, Condino F, Simone IL, Logroscino G et al (2012) Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 79(24):2315\u20132320. https:\/\/doi.org\/10.1212\/WNL.0b013e318278b618","journal-title":"Neurology"},{"key":"4600_CR34","doi-asserted-by":"publisher","first-page":"157.e151","DOI":"10.1016\/j.neurobiolaging.2017.11.011","volume":"64","author":"S Lattante","year":"2018","unstructured":"Lattante S, Pomponi MG, Conte A, Marangi G, Bisogni G, Patanella AK, Meleo E, Lunetta C et al (2018) ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis. Neurobiol Aging 64:157.e151-157.e155. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.11.011","journal-title":"Neurobiol Aging"},{"key":"4600_CR35","doi-asserted-by":"publisher","first-page":"116842","DOI":"10.1016\/j.jns.2020.116842","volume":"414","author":"JPN Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves JPN, de Andrade HMT, Cintra VP, Bonadia LC, Leoni TB, de Albuquerque M, Martins MP, de Borba FC et al (2020) CAG repeats \u2265 34 in ataxin-1 gene are associated with amyotrophic lateral sclerosis in a Brazilian cohort. J Neurol Sci 414:116842. https:\/\/doi.org\/10.1016\/j.jns.2020.116842","journal-title":"J Neurol Sci"},{"key":"4600_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2022.04.002","volume":"116","author":"ZF Nagy","year":"2022","unstructured":"Nagy ZF, P\u00e1l M, Salamon A, Kafui Esi Zodanu G, F\u00fcst\u00f6s D, Kliv\u00e9nyi P, Sz\u00e9ll M (2022) Re-analysis of the Hungarian amyotrophic lateral sclerosis population and evaluation of novel ALS genetic risk variants. Neurobiol Aging 116:1\u201311. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.04.002","journal-title":"Neurobiol Aging"},{"key":"4600_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neurobiolaging.2022.11.011","volume":"123","author":"M Farrugia Wismayer","year":"2023","unstructured":"Farrugia Wismayer M, Farrugia Wismayer A, Borg R, Bonavia K, Abela A, Chircop C, Aquilina J, Soler D et al (2023) Genetic landscape of ALS in Malta based on a quinquennial analysis. Neurobiol Aging 123:200\u2013207. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.11.011","journal-title":"Neurobiol Aging"},{"key":"4600_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ibneur.2021.02.002","volume":"10","author":"M Nel","year":"2021","unstructured":"Nel M, Mavundla T, Gultig K, Botha G, Mulder N, Benatar M, Wuu J, Cooley A et al (2021) Repeats expansions in ATXN2, NOP56, NIPA1 and ATXN1 are not associated with ALS in Africans. IBRO Neurosci Rep 10:130\u2013135. https:\/\/doi.org\/10.1016\/j.ibneur.2021.02.002","journal-title":"IBRO Neurosci Rep"},{"issue":"10","key":"4600_CR39","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1007\/s10072-022-06229-y","volume":"43","author":"A Ghezzi","year":"2022","unstructured":"Ghezzi A, Martinelli I, Carra S, Mediani L, Zucchi E, Simonini C, Gianferrari G, Fini N et al (2022) Missense mutation in ATXN2 gene (c.2860C>T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype. Neurol Sci 43(10):6087\u20136090. https:\/\/doi.org\/10.1007\/s10072-022-06229-y","journal-title":"Neurol Sci"},{"issue":"27","key":"4600_CR40","doi-asserted-by":"publisher","first-page":"9133","DOI":"10.1523\/jneurosci.0996-12.2012","volume":"32","author":"MP Hart","year":"2012","unstructured":"Hart MP, Gitler AD (2012) ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J Neurosci 32(27):9133\u20139142. https:\/\/doi.org\/10.1523\/jneurosci.0996-12.2012","journal-title":"J Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04600-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:12:03Z","timestamp":1741083123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04600-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4600"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04600-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the study was approved by the institutional ethics committee of Sichuan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from each participant or their primary caregiver.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}